Americans distrust drugs from China, India

Looks like pharma and the FDA need some damage control in the public opinion department. Americans don't trust drugs bearing a "Made in China" or "Made in India" label, according to a new study conducted by American University, and they blame drug companies for the rising cost of meds. The American public also doesn't understand the FDA's role in drug oversight and isn't thrilled with its performance on drug safety.

Though 88 percent of those polled said they thought drugs made in the U.S.A. are safe, only 14 percent trusted drugs made by the up-and-coming Chinese and Indian manufacturers. And 82 percent of those polled said they trust the FDA, but 47 percent said they thought the agency did only a fair or poor job. Nearly half thought drug company profits were the chief cause of escalating prescription costs.

- read this article from HealthDay

Related Articles:
FDA offers safety reforms to skeptical lawmakers. Report
China now leads India in ongoing clinical trials. Report
China to overhaul drug safety regulations. Report
Counterfeit drugs plaguing Big Pharma. Report

Free Webinar

From Patient Adherence to Manufacturing Ease - Why Softgels Make Sense for Rx

THIS WEEK: Join Thermo Fisher Scientific’s upcoming webinar to learn why softgels offer numerous benefits for Rx drug development, including enhanced bioavailability, patient compliance and easy scale-up. Register Today!

Suggested Articles

The new Community trial will first test Amgen's Otezla, Takeda's Takhzyro and UCB's zilucoplan in hospitalized patients.

Indivior faces a new lawsuit from RB, its former parent company, over a scheme to market opioid addiction therapy Suboxone Film.

A new FDA effort brings cancer drug labels to life in videotaped panels with experts, debuting its first episode on Seagen's MBC med Tukysa.